首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1525999

光動力療法（PDT）市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031年

Photodynamic Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024 - 2031

出版日期: 2024年07月26日 | 出版商:

Persistence Market Research | 英文 170 Pages | 商品交期: 2-5個工作天內

價格

簡介目錄

Persistence Market Research最近發布了一份關於全球光動力療法（PDT）市場的綜合報告。本報告對基本市場動態進行了詳細評估，包括市場驅動因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。

關鍵見解

光動力療法市場規模（2024年）：35億美元
預估市場規模（2031年）：74億美元
全球市場成長率（2024-2031年年複合成長率）：7.1%

光動力治療市場-報告範圍：

光動力療法在治療多種疾病中發揮重要作用，包括某些癌症、老年黃斑部病變（AMD）和癌前病變。 PDT 使用光敏藥物和特定波長的光來破壞目標細胞。光動力治療市場為醫院、腫瘤中心和眼科診所提供服務，並提供各種治療產品和技術，包括光敏劑、光源和傳輸系統。癌症和慢性病盛行率的增加、醫療保健投資的增加以及可提高治療效果和患者預後的 PDT 技術的進步推動了市場成長。

推動市場成長的因素：

全球光動力治療市場由幾個關鍵因素推動，例如癌症和其他需要有效治療方案的慢性疾病的盛行率不斷增加。對非侵入性和標靶治療的需求不斷成長，以及光敏劑化合物和光傳輸系統的進步推動市場擴張。眼科領域日益採用 PDT 來治療 AMD，以及開發具有提高療效和減少副作用的新 PDT 藥物也有助於市場擴張。此外，擴大醫療基礎設施和增加 PDT 研究活動也為市場進入者創造了新的機會。

市場限制因素：

雖然光動力療法市場有望實現成長，但它面臨著治療成本高、償付範圍有限和潛在副作用等挑戰。對於某些醫療保健系統和患者來說，PDT 設備和光敏劑的成本可能過高，尤其是在醫療保健預算有限的新興市場。此外，PDT 治療的償付有限以及對皮膚敏感和損傷等潛在副作用的擔憂對市場滲透構成了挑戰。解決這些障礙需要產業利益相關者、醫療保健提供者和政策制定者共同努力，以提高 PDT 解決方案的可近性和可負擔性。

市場機會：

由於技術創新、人口趨勢和不斷發展的治療模式，光動力治療市場呈現出巨大的成長機會。具有增強特異性和降低全身毒性的先進光敏劑的開發提供了新的治療可能性。此外，PDT與化療、免疫療法等其他治療方法的結合日益擴大其應用範圍。個人化醫療的興起以及對早期疾病檢測和治療的興趣日益濃厚，為 PDT 開闢了新的途徑。研發方面的策略性投資、策略聯盟以及引進具有成本效益的 PDT 解決方案對於利用新機會和維持市場領先地位非常重要。

本報告涵蓋的主要問題

推動全球光動力治療市場成長的關鍵因素是什麼？
哪些 PDT 應用和技術引領各個醫療領域的採用？
技術進步與創新如何改變 PDT 市場的競爭格局？
誰是光動力療法市場的主要公司？他們採取了哪些策略來維持其在市場上的地位？
全球光動力治療市場的新趨勢與未來前景如何？

簡介/主要發現
2019-2023年歷史市場規模（十億美元）分析：依產品類型
2024-2031年當前和未來市場規模（十億美元）的分析和預測：依產品類型
- 光敏感藥物
  - 血卟啉衍生物（HpD）
  - 氨基乙醯丙酸（ALA）
  - 苯並卟啉衍生物（BPD）
  - 泰克沙茶鹼
  - 二氫卟酚
  - 染料
- 設備
  - 拋棄式光纖傳輸設備
  - 二極體雷射
市場吸引力分析：依產品類型

第9章全球光動力治療市場分析：依應用

簡介/主要發現
2019-2023年過去的市場規模（十億美元）分析：依應用
2024-2031年當前和未來市場規模（十億美元）的分析和預測：依應用
- 基底細胞癌
- 日光角化症
- 其他
  - 牛皮癬
  - 痤瘡
  - 酒渣樣皮膚炎
  - 非小細胞肺癌
  - 食道癌
  - 眼科
市場吸引力分析：依應用分類

第10章全球光動力治療市場分析：依最終使用者

簡介/主要發現
2019-2023年歷史市場規模（十億美元）分析：依最終用戶
2024-2031年當前和未來市場規模（十億美元）的分析和預測：依最終用戶
- 醫院
- 私人皮膚科診所
- 雷射治療中心
- 癌症治療中心
- 水療和恢復中心
市場吸引力分析：依最終用戶分類

第11章北美光動力治療市場分析

第12章拉丁美洲光動力治療市場分析

第13章歐洲光動力治療市場分析

第14章南亞光動力療法市場分析

第15章東亞光動力治療市場分析

第16章大洋洲光動力治療市場分析

第17章中東與非洲光動力治療市場分析

第18章新興國家光動力治療市場分析

簡介
- 主要國家市值比例分析
- 世界與國家成長比較
中國光動力治療市場分析
- 簡介
- 依市場分類的市場金額比率分析
- 依市場分類的市場價值（十億美元）分析和預測
  - 依產品類型
  - 依最終用戶
  - 依用途
韓國光動力療法市場分析
- 簡介
- 依市場分類的市場金額比率分析
- 依市場分類的市場價值（十億美元）分析和預測
  - 依產品類型
  - 依最終用戶
  - 依用途
俄羅斯光動力療法市場分析
- 簡介
- 價格分析
- PEST分析
- 依市場分類的市場金額比率分析
- 依市場分類的市場價值（十億美元）分析和預測
  - 依產品類型
  - 依最終用戶
  - 依用途
- 韓國光動力治療市場 - 競爭格局

第19章競爭分析

競爭對手儀表板
競爭基準
競爭對手深度分析（光敏藥品製造商）
- Galderma SA
- Sun Pharmaceutical Industries Ltd.
- Biofrontera
- Novartis AG
- Allergan Plc
對競爭對手（PDT設備製造商）的深入分析
- Valeant Pharmaceuticals International, Inc
  - 摘要
  - 產品組合
  - 依細分市場的獲利能力（產品/通路/區域）
  - 銷售基地
  - 策略概述
    - 行銷策略
    - 產品策略
    - 通路策略
- Quest Pharmatech, Inc.
  - 摘要
  - 產品組合
  - 依細分市場的獲利能力（產品/通路/區域）
  - 銷售基地
  - 策略概述
    - 行銷策略
    - 產品策略
    - 通路策略
- Hologic, Inc.（Cynosure Inc.）
  - 摘要
  - 產品組合
  - 依細分市場的獲利能力（產品/通路/區域）
  - 銷售基地
  - 策略概述
    - 行銷策略
    - 產品策略
    - 通路策略

第20章使用的假設與縮寫

第21章研究方法

簡介目錄

Product Code: PMRREP25228

Persistence Market Research has recently released a comprehensive report on the worldwide market for photodynamic therapy (PDT). This report provides an in-depth assessment of essential market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

Photodynamic Therapy Market Size (2024): USD 3.5 Bn
Projected Market Value (2031): USD 7.4 Bn
Global Market Growth Rate (CAGR 2024- 2031): 7.1%

Photodynamic Therapy Market - Report Scope:

Photodynamic therapy plays a crucial role in the treatment of various medical conditions, including certain cancers, age-related macular degeneration (AMD), and precancerous lesions. PDT utilizes light-sensitive drugs and specific wavelengths of light to destroy targeted cells. The photodynamic therapy market serves hospitals, oncology centers, and ophthalmology clinics, offering various therapeutic products and technologies, including photosensitizers, light sources, and delivery systems. Market growth is driven by increasing incidence of cancer and chronic diseases, rising healthcare investments, and advancements in PDT technology, which improve treatment effectiveness and patient outcomes.

Market Growth Drivers:

The global photodynamic therapy market is driven by several key factors, including the growing prevalence of cancer and other chronic conditions requiring effective treatment options. The rising demand for non-invasive and targeted therapies, along with advancements in photosensitizer compounds and light delivery systems, is fostering market expansion. The increasing adoption of PDT in ophthalmology for AMD treatment and the development of novel PDT agents with improved efficacy and reduced side effects are also contributing to market growth. Additionally, expanding healthcare infrastructure and increased research activities in PDT are creating new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the photodynamic therapy market faces challenges related to high treatment costs, limited reimbursement coverage, and potential side effects. The cost of PDT equipment and photosensitizers can be prohibitive for some healthcare systems and patients, particularly in emerging markets with constrained healthcare budgets. Additionally, the limited availability of reimbursement for PDT procedures and concerns about potential adverse effects, such as skin sensitivity and damage, pose challenges for market penetration. Addressing these barriers requires collaboration between industry stakeholders, healthcare providers, and policymakers to improve access and affordability of PDT solutions.

Market Opportunities:

The photodynamic therapy market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving treatment paradigms. The development of advanced photosensitizers with enhanced specificity and reduced systemic toxicity offers new therapeutic possibilities. Moreover, the integration of PDT with other treatment modalities, such as chemotherapy and immunotherapy, is expanding its application scope. The rise of personalized medicine and the increasing focus on early disease detection and treatment are creating new avenues for PDT. Strategic investments in R&D, strategic partnerships, and the introduction of cost-effective PDT solutions are crucial for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the photodynamic therapy market globally?
Which PDT applications and technologies are leading the adoption across different medical fields?
How are technological advancements and innovations reshaping the competitive landscape of the PDT market?
Who are the key players contributing to the photodynamic therapy market, and what strategies are they employing to sustain their market presence?
What are the emerging trends and future prospects in the global photodynamic therapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global photodynamic therapy market, including Pfizer Inc., Theralase Technologies Inc., and Galderma S.A., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced PDT products and technologies, including novel photosensitizers, next-generation light delivery systems, and combination therapies. Collaborations with research institutions, healthcare providers, and regulatory bodies facilitate market access and technology adoption. Emphasis on clinical trials, evidence-based practices, and patient education is also crucial for driving market growth and enhancing treatment outcomes in the evolving PDT landscape.

Key Companies Profiled:

Givaudan
International Flavors & Fragrances Inc
MANE
Firmenich SA
BASF SE
Avon Products, Inc.
Shiseido Company
Limited, Chanel S.A
Clarins Fragrance Group
COTY INC., LVMH, L'Oreal Group
VIORYL S.A.
Zanos Ltd.
Artiste
INDESSO AROMA
Aroma Chemical Services International Gmbh

Photodynamic Therapy Market Segmentation

By Product Type

Photosensitizer Drugs
Photodynamic Therapy Devices

By Application

Cancer
Skin Conditions

By Region

North America
Europe
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Disease Epidemiology (2019)
3.2. Patient Treatment Journey
3.3. Phototherapy Treatment Patterns
3.4. Procedure Volume of Cosmetic Therapies

4. Key Success Factors

4.1. Recent Product Launches
4.2. Regulatory Scenario
4.3. Disease Epidemiology For Actinic Keratosis & Basal Cell Carcinoma (2019)
4.4. Strategic Promotional Strategies, By Manufacturers

5. Global Photodynamic Therapy Market - Pricing Analysis

5.1. Regional Pricing Analysis By Product Type
5.2. Global Average Pricing Analysis Benchmark

6. Global Photodynamic Therapy Market Demand (in Value or Size in US$ Bn ) Analysis 2019-2023 and Forecast, 2024 - 2031

6.1. Historical Market Value (US$ Bn ) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Bn ) Projections, 2024 - 2031
- 6.2.1. Y-o-Y Growth Trend Analysis
- 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

7.1. Macro-Economic Factors
- 7.1.1. Global GDP Growth Outlook
- 7.1.2. Global Healthcare Industry Outlook
7.2. Forecast Factors - Relevance & Impact
- 7.2.1. Recent Product Launches
- 7.2.2. Prevalence of Skin Disorders and Cancer
- 7.2.3. Adoption of Photodynamic Therapy For Skin and Cancer Treatment
- 7.2.4. Top Companies Historical Growth
- 7.2.5. Per Capita Healthcare Expenditure In Different Economies
7.3. Market Dynamics
- 7.3.1. Drivers
- 7.3.2. Restraints
- 7.3.3. Opportunity Analysis

8. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Product Type

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn ) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Product Type, 2024 - 2031
- 8.3.1. Photosensitizer Drugs
  - 8.3.1.1. Hematoporphyrin derivative (HpD)
  - 8.3.1.2. Aminolevulinic acid (ALA)
  - 8.3.1.3. Benzoporphyrin derivative (BPD)
  - 8.3.1.4. Texaphyrins
  - 8.3.1.5. Chlorins
  - 8.3.1.6. Dyes
- 8.3.2. Devices
  - 8.3.2.1. Disposable Fiberoptic Light Delivery Devices
  - 8.3.2.2. Diode Laser
8.4. Market Attractiveness Analysis By Product Type

9. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Application

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn ) Analysis By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Application, 2024 - 2031
- 9.3.1. Basal Cell Carcinoma
- 9.3.2. Actinic Keratosis
- 9.3.3. Others
  - 9.3.3.1. Psoriasis
  - 9.3.3.2. Acne
  - 9.3.3.3. Rosacea
  - 9.3.3.4. Non-Small Cell Lung Cancer
  - 9.3.3.5. Esophageal Cancer
  - 9.3.3.6. Ophthalmology
9.4. Market Attractiveness Analysis By Application

10. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by End User

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn ) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By End User, 2024 - 2031
- 10.3.1. Hospitals
- 10.3.2. Private Dermatology Clinics
- 10.3.3. Laser Therapy Centers
- 10.3.4. Cancer Treatment Centers
- 10.3.5. Spas and Rejuvenation Centers
10.4. Market Attractiveness Analysis By End User

11. North America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 11.4.1. By Country
  - 11.4.1.1. U.S.
  - 11.4.1.2. Canada
- 11.4.2. By Product Type
- 11.4.3. By Application
- 11.4.4. By End User
11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Product Type
- 11.5.3. By Application
- 11.5.4. By End User
11.6. Market Trends

12. Latin America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 12.4.1. By Country
  - 12.4.1.1. Brazil
  - 12.4.1.2. Mexico
  - 12.4.1.3. Rest of Latin America
- 12.4.2. By Product Type
- 12.4.3. By Application
- 12.4.4. By End User
12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Product Type
- 12.5.3. By Application
- 12.5.4. By End User
12.6. Market Trends

13. Europe Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 13.4.1. By Country
  - 13.4.1.1. Germany
  - 13.4.1.2. Italy
  - 13.4.1.3. France
  - 13.4.1.4. U.K.
  - 13.4.1.5. Spain
  - 13.4.1.6. Russia
  - 13.4.1.7. Poland
  - 13.4.1.8. Rest of Europe
- 13.4.2. By Product Type
- 13.4.3. By Application
- 13.4.4. By End User
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Product Type
- 13.5.3. By Application
- 13.5.4. By End User
13.6. Market Trends

14. South Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 14.4.1. By Country
  - 14.4.1.1. India
  - 14.4.1.2. Thailand
  - 14.4.1.3. Indonesia
  - 14.4.1.4. Malaysia
  - 14.4.1.5. Rest of South Asia
- 14.4.2. By Product Type
- 14.4.3. By Application
- 14.4.4. By End User
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Product Type
- 14.5.3. By Application
- 14.5.4. By End User
14.6. Market Trends

15. East Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 15.4.1. By Country
  - 15.4.1.1. China
  - 15.4.1.2. Japan
  - 15.4.1.3. South Korea
- 15.4.2. By Product Type
- 15.4.3. By Application
- 15.4.4. By End User
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product Type
- 15.5.3. By Application
- 15.5.4. By End User
15.6. Market Trends

16. Oceania Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 16.4.1. By Country
  - 16.4.1.1. Australia
  - 16.4.1.2. New Zealand
- 16.4.2. By Product Type
- 16.4.3. By Application
- 16.4.4. By End User
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Product Type
- 16.5.3. By Application
- 16.5.4. By End User
16.6. Market Trends

17. Middle East and Africa Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
- 17.4.1. By Country
  - 17.4.1.1. GCC Countries
  - 17.4.1.2. South Africa
  - 17.4.1.3. Rest of Middle East and Africa
- 17.4.2. By Product Type
- 17.4.3. By Application
- 17.4.4. By End User
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Product Type
- 17.5.3. By Application
- 17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis

18. Emerging Countries Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

18.1. Introduction
- 18.1.1. Market Value Proportion Analysis, By Key Countries
- 18.1.2. Global Vs. Country Growth Comparison
18.2. China Photodynamic Therapy Market Analysis
- 18.2.1. Introduction
- 18.2.2. Market Value Proportion Analysis by Market Taxonomy
- 18.2.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
  - 18.2.3.1. By Product Type
  - 18.2.3.2. By End User
  - 18.2.3.3. By Application
18.3. South Korea Photodynamic Therapy Market Analysis
- 18.3.1. Introduction
- 18.3.2. Market Value Proportion Analysis by Market Taxonomy
- 18.3.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
  - 18.3.3.1. By Product Type
  - 18.3.3.2. By End User
  - 18.3.3.3. By Application
18.4. Russia Photodynamic Therapy Market Analysis
- 18.4.1. Introduction
- 18.4.2. Pricing Analysis
- 18.4.3. PEST Analysis
- 18.4.4. Market Value Proportion Analysis by Market Taxonomy
- 18.4.5. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
  - 18.4.5.1. By Product Type
  - 18.4.5.2. By End User
  - 18.4.5.3. By Application
- 18.4.6. South Korea Photodynamic Therapy Market - Competition Landscape

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive (Photosensitizer Drug Manufactures)
- 19.3.1. Galderma S.A.
  - 19.3.1.1. Overview
  - 19.3.1.2. Product Portfolio
  - 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.1.4. Sales Footprint
  - 19.3.1.5. Strategy Overview
    - 19.3.1.5.1. Marketing Strategy
    - 19.3.1.5.2. Product Strategy
    - 19.3.1.5.3. Channel Strategy
- 19.3.2. Sun Pharmaceutical Industries Ltd.
  - 19.3.2.1. Overview
  - 19.3.2.2. Product Portfolio
  - 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.2.4. Sales Footprint
  - 19.3.2.5. Strategy Overview
    - 19.3.2.5.1. Marketing Strategy
    - 19.3.2.5.2. Product Strategy
    - 19.3.2.5.3. Channel Strategy
- 19.3.3. Biofrontera
  - 19.3.3.1. Overview
  - 19.3.3.2. Product Portfolio
  - 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.3.4. Sales Footprint
  - 19.3.3.5. Strategy Overview
    - 19.3.3.5.1. Marketing Strategy
    - 19.3.3.5.2. Product Strategy
    - 19.3.3.5.3. Channel Strategy
- 19.3.4. Novartis AG
  - 19.3.4.1. Overview
  - 19.3.4.2. Product Portfolio
  - 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.4.4. Sales Footprint
  - 19.3.4.5. Strategy Overview
    - 19.3.4.5.1. Marketing Strategy
    - 19.3.4.5.2. Product Strategy
    - 19.3.4.5.3. Channel Strategy
- 19.3.5. Allergan Plc
  - 19.3.5.1. Overview
  - 19.3.5.2. Product Portfolio
  - 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.5.4. Sales Footprint
  - 19.3.5.5. Strategy Overview
    - 19.3.5.5.1. Marketing Strategy
    - 19.3.5.5.2. Product Strategy
    - 19.3.5.5.3. Channel Strategy
19.4. Competition Deep Dive (PDT Device Manufactures)
- 19.4.1. Valeant Pharmaceuticals International, Inc.
  - 19.4.1.1. Overview
  - 19.4.1.2. Product Portfolio
  - 19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.4.1.4. Sales Footprint
  - 19.4.1.5. Strategy Overview
    - 19.4.1.5.1. Marketing Strategy
    - 19.4.1.5.2. Product Strategy
    - 19.4.1.5.3. Channel Strategy
- 19.4.2. Quest Pharmatech, Inc.
  - 19.4.2.1. Overview
  - 19.4.2.2. Product Portfolio
  - 19.4.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.4.2.4. Sales Footprint
  - 19.4.2.5. Strategy Overview
    - 19.4.2.5.1. Marketing Strategy
    - 19.4.2.5.2. Product Strategy
    - 19.4.2.5.3. Channel Strategy
- 19.4.3. Hologic, Inc. (Cynosure Inc.)
  - 19.4.3.1. Overview
  - 19.4.3.2. Product Portfolio
  - 19.4.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.4.3.4. Sales Footprint
  - 19.4.3.5. Strategy Overview
    - 19.4.3.5.1. Marketing Strategy
    - 19.4.3.5.2. Product Strategy
    - 19.4.3.5.3. Channel Strategy